Related Experiment Video
Updated: Jul 11, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
B cell biology and dysfunction in SLE
1University of Rochester School of Medicine, Rochester, NY 14642, USA. jennifer_anolik@URMC.rochester.edu
Bulletin of the NYU Hospital for Joint Diseases
|October 10, 2007
Summary
Systemic lupus erythematosus (SLE) involves B cell defects contributing to autoimmunity through autoantibodies and other mechanisms. Therapeutic strategies now focus on targeting these B cells in SLE patients.
Area of Science:
- Immunology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- B cells play a central role in SLE pathogenesis, with defects identified in signaling, cytokine regulation, and development.
- Abnormalities in B cell tolerance are implicated in SLE.
Purpose of the Study:
- To review the multifaceted role of B cells in SLE pathogenesis.
- To discuss both antibody-dependent and antibody-independent B cell functions in SLE.
- To highlight the emerging therapeutic focus on B cell-targeted interventions for SLE.
Main Methods:
- Review of existing research on B cell function and defects in SLE.
- Analysis of antibody-dependent and antibody-independent mechanisms.
- Examination of therapeutic strategies targeting B cells.
Main Results:
- B cell defects contribute to SLE through autoantibody production and other pathways.
- Autoantibodies mediate autoimmunity via hypersensitivity reactions and by activating innate immune cells.
- Autoantibody-independent B cell functions include antigen presentation and immune modulation.
Conclusions:
- B cells are critically involved in SLE pathogenesis through diverse mechanisms.
- Targeting B cells represents a promising therapeutic avenue for SLE treatment.
More Related Videos
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:11Fibril-associated Collagen
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:05Type IV Collagen of Basal Lamina
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
A type IV collagen molecule has six alpha chains which can exist in...